What is GoodRx?
Founded in 2011 and headquartered in Santa Monica, California, GoodRx operates a sophisticated price comparison platform designed to empower consumers with actionable data regarding prescription drug costs. The company's value proposition centers on transparency, providing users with access to negotiated prices and curated, geographically relevant pricing information. Beyond its core price-comparison engine, GoodRx has diversified its service portfolio to include subscription-based offerings, pharmaceutical manufacturer solutions, and integrated telehealth services via the GoodRx Care platform. By facilitating seamless transactions between consumers and pharmacies, the firm effectively optimizes the prescription fulfillment process, serving as a vital intermediary in the complex U.S. healthcare market.
How much funding has GoodRx raised?
GoodRx has raised a total of $2.2B across 3 funding rounds:
Angel/Seed
$1M
Stock Offering
$1.1B
Stock Offering
$1.1B
Angel/Seed (2012): $1M with participation from Highland Capital Partners, Lerer Ventures, and SV Angel
Stock Issuance/Offering (2020): $1.1B, investors not publicly disclosed
Stock Issuance/Offering (2020): $1.1B, investors not publicly disclosed
Key Investors in GoodRx
Highland Capital Partners
Highland Capital Partners is a venture capital firm that focuses on investing in entrepreneurs and innovative startups. With a track record of 200 exits, over 50 IPOs, and 40 unicorns, the firm manages $7 billion in assets under management.
Lerer Ventures
Kenneth Lerer Associates LLC is a company that operates in the Venture Capital & Private Equity industry, focusing on early-stage investments in high-growth technology companies.
SV Angel
SV Angel is a long-term investment firm dedicated to supporting founders in creating impactful businesses by providing essential resources, strategic insights, and a vast network to help companies scale.
What's next for GoodRx?
With the capital secured through its recent strategic financing, GoodRx is well-positioned to accelerate its expansion into broader healthcare services. The company's strategic roadmap likely involves deepening its integration with pharmacy benefit managers and enhancing its telehealth capabilities to capture a larger share of the digital health market. As the firm continues to navigate the evolving regulatory environment of the pharmaceutical industry, its focus will remain on scaling its manufacturer solutions and refining its consumer-facing tools. This phase of growth suggests a transition toward becoming a holistic health management platform, leveraging its massive user base to drive further innovation in patient-centric care and cost-containment strategies.
See full GoodRx company page
